A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors
NCT04397276
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
82
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms
Interventions
DRUG:
JNJ-70218902
Sponsor
Janssen Research & Development, LLC